GENOTROPIN 1.6 MG
SOMATROPIN : 1.6 MG · DIN 02401819 · PFIZER CANADA ULC
Health Canada status: MARKETED
What is GENOTROPIN?
GENOTROPIN 1.6 MG contains SOMATROPIN : 1.6 MG. It is listed in the Health Canada Drug Product Database under DIN 02401819, held by PFIZER CANADA ULC, supplied as POWDER FOR SOLUTION for SUBCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 18-Sep-2013. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is GENOTROPIN used for?
GENOTROPIN (somatropin for injection) is indicated for the long-term treatment of children who have growth failure due to an inadequate secretion of endogenous growth hormone (growth hormone deficiency (GHD)). It is also indicated for the treatment of growth failure in short children born Small for Gestational Age (SGA) who fail to achieve catch-up growth, short stature associated with Turner syndrome, long-term treatment of idiopathic short stature (ISS), and treatment of pediatric patients who have growth failure due to Prader-Willi syndrome (PWS). In adults, GENOTROPIN is indicated for replacement of endogenous growth hormone in adults with growth hormone deficiency.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02401819 |
|---|---|
| Brand name | GENOTROPIN |
| Generic / active ingredient | SOMATROPIN : 1.6 MG |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 1.6 MG |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Schedule | Prescription |
| ATC code | H01AC01 SOMATROPIN |
| AHFS class | 68:28.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 18-Sep-2013 |
| Original market date | 2013-09-18 00:00:00 |
How is it stored and handled?
null
How is it supplied?
5 mg, 5.3 mg, 12 mg pre-filled pen, GoQuick and 0.2 mg, 0.4 mg, 0.6 mg, 0.8 mg, 1.0 mg, 1.2 mg, 1.4 mg, 1.6 mg, 1.8 mg, and 2.0 mg prefilled syringe, MiniQuick
What can be used instead?
Other Canadian products sharing ATC code H01AC01 SOMATROPIN. 21 of 49 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| GENOTROPIN | 0.2 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02401746 |
| GENOTROPIN | 0.4 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02401754 |
| GENOTROPIN | 0.6 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02401762 |
| GENOTROPIN | 0.8 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02401770 |
| GENOTROPIN | 1 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02401789 |
| GENOTROPIN | 1.2 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02401797 |
| GENOTROPIN | 1.4 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02401800 |
| GENOTROPIN | 1.8 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02401827 |
| GENOTROPIN | 12 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02401711 |
| GENOTROPIN | 2 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02401835 |
Who else supplies SOMATROPIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. SOMATROPIN appears in 1520 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.